Perioperative Elafin for ischaemia-reperfusion injury during coronary artery bypass graft surgery: A randomised-controlled trial

Heart

Volumn 101, Issue 20, 2015, Pages 1639-1645

  Alam, S R ^a   Lewis, S C ^a   Zamvar, V ^b   Pessotto, R ^b   Dweck, M R ^a   Krishan, A ^a   Goodman, K ^a   Oatey, K ^a   Harkess, R ^a   Milne, L ^a   Thomas, S ^a   Mills, N M ^a   Moore, C ^b   Semple, S ^c   Wiedow, O ^d   Stirrat, C ^a   Mirsadraee, S ^c   Newby, D E ^a,c   Henriksen, P A ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CREATININE; ELAFIN; ELASTASE; HIGH SENSITIVE C REACTIVE PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; MYELOPEROXIDASE; PLACEBO; TROPONIN I; UNCLASSIFIED DRUG; PROTEINASE INHIBITOR; RECOMBINANT PROTEIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; ATRIAL FIBRILLATION; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG BLOOD LEVEL; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HEART INFARCTION; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 2 CLINICAL TRIAL; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY; RESPIRATORY TRACT DISEASE; SINGLE DRUG DOSE; ADVERSE EFFECTS; CORONARY ARTERY DISEASE; DOUBLE BLIND PROCEDURE; FOLLOW UP; INTRAOPERATIVE COMPLICATIONS; INTRAOPERATIVE PERIOD; INTRAVENOUS DRUG ADMINISTRATION; MYOCARDIAL REPERFUSION INJURY; RETROSPECTIVE STUDY;

CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DOUBLE-BLIND METHOD; ELAFIN; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRAVENOUS; INTRAOPERATIVE COMPLICATIONS; INTRAOPERATIVE PERIOD; MAGNETIC RESONANCE IMAGING, CINE; MYOCARDIAL REPERFUSION INJURY; PROTEASE INHIBITORS; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES;

EID: 84945489608     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2015-307745     Document Type: Article

References (27)

1. Hansen PR. Role of neutrophils in myocardial ischemia and reperfusion. Circulation 1995;91:1872.
2. Vinten-Johansen J. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc Res 2004;61:481-97.
3. Butler J, Parker D, Pillai R, et al. Effect of cardiopulmonary bypass on systemic release of neutrophil elastase and tumor necrosis factor. J Thorac Cardiovasc Surg 1993;105:25-30.
4. Wakayama F, Fukuda I, Suzuki Y, et al. Neutrophil elastase inhibitor, sivelestat, attenuates acute lung injury after cardiopulmonary bypass in the rabbit endotoxemia model. Ann Thorac Surg 2007;83:153-60.
5. Hausenloy DJ, Mwamure PK, Venugopal V, et al. Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. Lancet 2007;370:575-9.
6. Sallenave JM, Ryle AP. Purification and characterization of elastase-specific inhibitor. Sequence homology with mucus proteinase inhibitor. Biol Chem Hoppe Seyler 1991;372:13-21.
7. Wiedow O, Luademann J, Utecht B. Elafin is a potent inhibitor of proteinase 3. Biochem Biophys Res Commun 1991;174:6-10.
8. Henriksen PA, Hitt M, Xing Z, et al. Adenoviral gene delivery of elafin and secretory leukocyte protease inhibitor attenuates NF-B-dependent inflammatory responses of human endothelial cells and macrophages to atherogenic stimuli. J Immunol 2004;172:4535.
9. Sallenave JM. The role of secretory leukocyte proteinase inhibitor and elafin (elastase-specific inhibitor/skin-derived antileukoprotease) as alarm antiproteinases in inflammatory lung disease. Respir Res 2000;1:87-92.
10. Crinnion J, Homer-Vanniasinkam S, Hatton R, et al. Role of neutrophil depletion and elastase inhibition in modifying skeletal muscle reperfusion injury. Cardiovasc Surg 1994;2:749.
11. Tiefenbacher CP, Ebert M, Niroomand F, et al. Inhibition of elastase improves myocardial function after repetitive ischaemia and myocardial infarction in the rat heart. Pflugers Arch 1997;433:563-70.
12. Ohta K, Nakajima T, Cheah AY, et al. Elafin-overexpressing mice have improved cardiac function after myocardial infarction. Am J Physiol Heart Circ Physiol 2004;287:H286-92.
13. Zaidi SH, Hui CC, Cheah AY, et al. Targeted overexpression of elafin protects mice against cardiac dysfunction and mortality following viral myocarditis. J Clin Invest 1999;103:1211-19.
14. Zaidi SH, You XM, Ciura S, et al. Overexpression of the serine elastase inhibitor elafin protects transgenic mice from hypoxic pulmonary hypertension. Circulation 2002;105:516-21.
15. Zaidi SH, You XM, Ciura S, et al. Suppressed smooth muscle proliferation and inflammatory cell invasion after arterial injury in elafin-overexpressing mice. J Clin Invest 2000;105:1687-95.
16. Mills NL, Churchhouse AM, Lee KK, et al. Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome. JAMA 2011;305:1210-16.
17. Mills NL, Lee KK, McAllister DA, et al. Implications of lowering threshold of plasma troponin concentration in diagnosis of myocardial infarction: cohort study. BMJ 2012;344:e1533.
18. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol 2012;60:1581-98.
19. Alam SR, Newby DE, Henriksen PA. Role of the endogenous elastase inhibitor, elafin, in cardiovascular injury: from epithelium to endothelium. Biochem Pharmacol 2012;83:695-704.
20. Kersten JR, Schmeling TJ, Pagel PS, et al. Isoflurane mimics ischemic preconditioning via activation of K(ATP) channels: reduction of myocardial infarct size with an acute memory phase. Anesthesiology 1997;87:361-70.
21. Steuer J, Bjerner T, Duvernoy O, et al. Visualisation and quantification of peri-operative myocardial infarction after coronary artery bypass surgery with contrast-enhanced magnetic resonance imaging. Eur Heart J 2004;25:1293-9.
22. Verrier ED, Shernan SK, Taylor KM, et al. Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trial. JAMA 2004;291:2319-27.
23. Croal BL, Hillis GS, Gibson PH, et al. Relationship between postoperative cardiac troponin I levels and outcome of cardiac surgery. Circulation 2006;114:1468-75.
24. Baldus S, Eiserich JP, Mani A, et al. Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration. J Clin Invest 2001;108:1759-70.
25. Rudolph TK, Schaper N, Klinke A, et al. Liberation of vessel-adherent myeloperoxidase reflects plaque burden in patients with stable coronary artery disease. Atherosclerosis 2013;231:354-8.
26. Cowan B, Baron O, Crack J, et al. Elafin, a serine elastase inhibitor, attenuates post-cardiac transplant coronary arteriopathy and reduces myocardial necrosis in rabbits afer heterotopic cardiac transplantation. J Clin Invest 1996;97:2452-68.
27. Day JR, Taylor KM. The systemic inflammatory response syndrome and cardiopulmonary bypass. Int J Surg 2005;3:129-40.